We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

307 hedge funds and large institutions have $8B invested in CUBIST PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 66 increasing their positions, 90 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more funds holding in top 10

Funds holding in top 10: 635 (+29)

82% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 68

51% more capital invested

Capital invested by funds: $5.31B → $8B (+$2.69B)

21% more funds holding

Funds holding: 254307 (+53)

27% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 90

54% less call options, than puts

Call options by funds: $329M | Put options by funds: $708M

Holders
307
Holders Change
+53
Holders Change %
+20.87%
% of All Funds
8.19%
Holding in Top 10
35
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+483.33%
% of All Funds
0.93%
New
124
Increased
66
Reduced
90
Closed
68
Calls
$329M
Puts
$708M
Net Calls
-$379M
Net Calls Change
-$371M
Name Holding Trade Value Shares
Change
Change in
Stake
NFG
301
Next Financial Group
Texas
$5K +$3.89K +50 New
LNB
302
Ledyard National Bank
$3K
FHA
303
First Horizon Advisors
Tennessee
$2K
Northwestern Mutual Wealth Management
304
Northwestern Mutual Wealth Management
Wisconsin
$1K
FPFS
305
First Personal Financial Services
North Carolina
$1K +$777 +10 New
NG
306
NatWest Group
United Kingdom
$891 +$688K +8,849 New
PC
307
PointState Capital
New York
-$109M -1,650,000 Closed
HM
308
HealthCor Management
New York
-$73M -1,100,000 Closed
GTP
309
Global Thematic Partners
New York
-$43.7M -658,193 Closed
CCI
310
Columbus Circle Investors
-$36.8M -554,960 Closed
TCM
311
Tekla Capital Management
Massachusetts
-$32.8M -494,454 Closed
Neuberger Berman Group
312
Neuberger Berman Group
New York
-$22.8M -343,028 Closed
Point72 Asset Management
313
Point72 Asset Management
Connecticut
-$22.6M -340,200 Closed
AAMU
314
Amundi Asset Management US
Massachusetts
-$22.4M -338,388 Closed
SIMG
315
Stephens Investment Management Group
Texas
-$22.1M -333,169 Closed
RG
316
Redmile Group
California
-$18.8M -283,756 Closed
Axa
317
Axa
France
-$13.9M -209,917 Closed
SGA
318
Sector Gamma AS
Norway
-$13.3M -199,990 Closed
RA
319
Royce & Associates
New York
-$13.1M -197,980 Closed
ICM
320
IronBridge Capital Management
Illinois
-$11.9M -179,462 Closed
Fidelity International
321
Fidelity International
Bermuda
-$11.5M -173,787 Closed
TAM
322
THB Asset Management
Connecticut
-$11.1M -166,665 Closed
California Public Employees Retirement System
323
California Public Employees Retirement System
California
-$9.24M -139,300 Closed
Thrivent Financial for Lutherans
324
Thrivent Financial for Lutherans
Minnesota
-$7.85M -118,386 Closed
TCM
325
Tamarack Capital Management
California
-$7.3M -110,000 Closed

CBST Hedge Fund Activity: Q4 2014 in Review

307 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q4 2014, worth a combined $8B — up 51% from $5.31B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new CBST positions and 68 closed out — a net gain of 56 holders — while 66 added to existing stakes and 90 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $222M. The largest seller was Putnam Investments, cutting an estimated $477M.

  • 307 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q4 2014, up from 254 in Q3 2014.
  • Funds reported $8B of CUBIST PHARMACEUTICALS INC stock for Q4 2014, up 51% quarter-over-quarter.
  • 124 funds opened new CUBIST PHARMACEUTICALS INC positions in Q4 2014 and 68 closed out, a net change of +56 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q4 2014 was HBK Investments, an estimated $222M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q4 2014 was Putnam Investments, an estimated $477M sold.

Based on aggregated 13F filings for Q4 2014.